Block 9 - Week 6 Flashcards
Dacarbazine
Alkylating agent - attaches it’s alkyl group to DNA bases resulting in DNA fragmentation by repair enzymes hence preventing DNA synthesis and RNA transcription from affected DNA
Cyclophosphamide
Alkylating agent - must be activated in the liver to its metabolite Aldo phosphamide
Rituximab
Monoclonal antibody which binds to CD20 antigen found on surface of normal and malignant B lymphocytes and mediates cell lysis - used in treatment of non-Hodgkins lymphoma
Doxorubicin
DNA/RNA synthesis inhibitor
Antibiotic and anti tumour drug
Complexes with DNA by intercalation between base pairs and inhibits topoisomerase II activity
Paclitaxal
Microtubule stabilisation agent - binds to B-Tubulin causing hyper stabilisation of micro tubule reorganising cytoskeleton which is Important for cell function and key to cellular transport
In cancer it inhibits Bcl-2 (anti-apoptotic molecule which prevents apoptosis of cancer cells) so that apoptosis of cancer cells can take place
Tamoxifen
Selective oestrogen receptor modulator . Binds to estrogen receptor hence preventing oestrogen from binding so that the cancer cells can’t get the oestrogen (hormones ) they need to proliferate
5-fluorouracil
Pyrimidine analogue
Antimetabolite which masquerade as purine and pyrimidine and become incorporated into DNA during the S phase of the cell cycle stopping normal development and division
Inhibiting DNA and RNA synthesis and causing cell death
Etoposide
DNA topoisomerase II inhibitor therefore inhibiting DNA re-ligation causing critical errors in DNA synthesis and leading to apoptosis of cancer cell
S phase and G2 phase of cell division
Vinblastine
Tubulin polymerase inhibitor - inhibits mitosis at metaphase causes the crystallisation of micro tubule at the mitosis spindle leading to motorists arrest or cell death
Imatinib
Tyrosine kinase inhibitor
Binds to the BCR-ABL tyrosine kinase leading to inhibition of cell proliferation driven by Bcr -able positive cells whilst inducing apoptosis
Tretinoin
Vitamin A analogue binds to alpha , beta RARs(retinoic acid receptors) which are associated with the development of acute promyelocytic leukaemia